Catalyst Brief

← Calendar

Readoutin 13d

Galderma R&D — Trifarotene

Phase 3 primary completion: A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris.

Date
Dec 2026
Type
Readout
Indication
Acne Vulgaris

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.